Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis
暂无分享,去创建一个
[1] M. Ferrari,et al. Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis , 2021, Science.
[2] I. Shimomura,et al. A low serum IGF-1 is correlated with sarcopenia in subjects with type 1 diabetes mellitus: Findings from a post-hoc analysis of the iDIAMOND study. , 2021, Diabetes research and clinical practice.
[3] L. Jia,et al. M2-like tumour-associated macrophage-secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway , 2021, Molecular medicine reports.
[4] Caimei Yang,et al. Effects of Bacillus subtilis and Bacillus licheniformis on growth performance, immunity, short chain fatty acid production, antioxidant capacity, and cecal microflora in broilers , 2021, Poultry science.
[5] Yufei Liu,et al. Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways , 2021, Frontiers in Oncology.
[6] S. Yachida,et al. The gut microbiota associated with high‐Gleason prostate cancer , 2021, Cancer Science.
[7] G. Netto,et al. Gut Microbiota–Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 Signaling , 2021, Cancer Research.
[8] M. Sohrabi,et al. Role of microbiota-derived short-chain fatty acids in cancer development and prevention. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[9] Xinghuan Wang,et al. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin‐like growth factor 1 knockdown , 2021, The Prostate.
[10] Dan Chen,et al. Escherichia coli Exopolysaccharides Induced by Ceftriaxone Regulated Human Gut Microbiota in vitro , 2021, Frontiers in Microbiology.
[11] F. Ronchi,et al. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology , 2020, Frontiers in Immunology.
[12] P. Schulz,et al. The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology. , 2020, Pharmacological research.
[13] Wei Chen,et al. A High-Fat Diet Increases Gut Microbiota Biodiversity and Energy Expenditure Due to Nutrient Difference , 2020, Nutrients.
[14] D. Huo,et al. Circulating Insulin-Like Growth Factor-1 and Risk of Total and 19 Site-Specific Cancers: Cohort Study Analyses from the UK Biobank , 2020, Cancer Epidemiology, Biomarkers & Prevention.
[15] K. Takeda,et al. Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells , 2020, EBioMedicine.
[16] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[17] S. Plymate,et al. Antitumor Activity of the IGF-1/IGF-2–Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models , 2020, Molecular Cancer Therapeutics.
[18] N. Nonomura,et al. Influence of Diet and Nutrition on Prostate Cancer , 2020, International journal of molecular sciences.
[19] R. Frozza,et al. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication , 2020, Frontiers in Endocrinology.
[20] T. van de Wiele,et al. Supplementation of a propionate-producing consortium improves markers of insulin resistance in an in vitro model of gut-liver axis. , 2020, American journal of physiology. Endocrinology and metabolism.
[21] T. Key,et al. Hormone‐related diseases and prostate cancer: An English national record linkage study , 2019, International journal of cancer.
[22] B. Schroeder,et al. Microbiota and mucosal defense in IBD: an update , 2019, Expert review of gastroenterology & hepatology.
[23] H. V. van Duyvenvoorde,et al. Phenotypic Features and Response to GH Treatment of Patients With a Molecular Defect of the IGF-1 Receptor. , 2019, The Journal of clinical endocrinology and metabolism.
[24] T. Habuchi,et al. Research Evidence on High-Fat Diet-Induced Prostate Cancer Development and Progression , 2019, Journal of clinical medicine.
[25] Adrian V. Lee,et al. Bad to the Bone: The Role of the Insulin-Like Growth Factor Axis in Osseous Metastasis , 2019, Clinical Cancer Research.
[26] N. Nonomura,et al. Metformin inhibits prostate cancer growth induced by a high‐fat diet in Pten‐deficient model mice , 2018, International journal of urology : official journal of the Japanese Urological Association.
[27] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[28] F. Hakuno,et al. IGF1 receptor signaling pathways. , 2018, Journal of molecular endocrinology.
[29] D. Clemmons. Role of IGF-binding proteins in regulating IGF responses to changes in metabolism. , 2018, Journal of molecular endocrinology.
[30] S. Mohan,et al. 40 YEARS OF IGF1: Role of IGF1 and EFN–EPH signaling in skeletal metabolism , 2018, Journal of Molecular Endocrinology.
[31] R. Kineman,et al. 40 YEARS of IGF1: Understanding the tissue-specific roles of IGF1/IGF1R in regulating metabolism using the Cre/loxP system. , 2018, Journal of molecular endocrinology.
[32] Longhuo Wu,et al. Effects of the intestinal microbial metabolite butyrate on the development of colorectal cancer , 2018, Journal of Cancer.
[33] G. Netto,et al. High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling , 2018, Clinical Cancer Research.
[34] H. Nandeesha,et al. Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia , 2018, The aging male : the official journal of the International Society for the Study of the Aging Male.
[35] J. Wright,et al. A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC) , 2018, Investigational New Drugs.
[36] Y. Naito,et al. Gut microbiota in the pathogenesis of inflammatory bowel disease , 2018, Clinical Journal of Gastroenterology.
[37] Lee B. Smith,et al. Insulin and IGF1 receptors are essential for the development and steroidogenic function of adult Leydig cells , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] B. Jiang,et al. Insulin-like growth factor-I induces chemoresistence to docetaxel by inhibiting miR-143 in human prostate cancer , 2017, Oncotarget.
[39] Hannah D. Holscher,et al. Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans , 2017, Medicine and science in sports and exercise.
[40] C. Xue,et al. Dietary fucoidan of Acaudina molpadioides alters gut microbiota and mitigates intestinal mucosal injury induced by cyclophosphamide. , 2017, Food & function.
[41] R. Schwabe,et al. The gut microbiome and liver cancer: mechanisms and clinical translation , 2017, Nature Reviews Gastroenterology &Hepatology.
[42] A. Wolk,et al. Dairy intake in relation to prostate cancer survival , 2017, International journal of cancer.
[43] S. Roy,et al. Microbes and Cancer. , 2017, Annual review of immunology.
[44] L. Bosurgi,et al. IGF1 Shapes Macrophage Activation in Response to Immunometabolic Challenge. , 2017, Cell reports.
[45] U. Lerner,et al. Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone , 2017, Clinical & Experimental Metastasis.
[46] Tom R. Gaunt,et al. Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis , 2017, Cancer Causes & Control.
[47] W. Garrett,et al. Gut microbiota induce IGF-1 and promote bone formation and growth , 2016, Proceedings of the National Academy of Sciences.
[48] E. Seto,et al. HDACs and HDAC Inhibitors in Cancer Development and Therapy. , 2016, Cold Spring Harbor perspectives in medicine.
[49] M. Blaut,et al. Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high‐fat diet‐induced obesity , 2016, Molecular nutrition & food research.
[50] Kenichi Yoshida,et al. The influence of type 2 diabetes on serum GH and IGF-I levels in hospitalized Japanese patients. , 2016, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[51] C. Kahn,et al. Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function , 2016, Diabetes.
[52] T. Preston,et al. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.
[53] M. Usami,et al. Gut microbiota and host metabolism in liver cirrhosis. , 2015, World journal of gastroenterology.
[54] H. Klocker,et al. The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer. , 2015, Cancer letters.
[55] J. Verne,et al. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010 , 2015, BMC Medicine.
[56] I. Amit,et al. Host microbiota constantly control maturation and function of microglia in the CNS , 2015, Nature Neuroscience.
[57] C. Kahn,et al. Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis. , 2015, Cell reports.
[58] Chieh-Hsi Wu,et al. A population‐based nested case–control study: the use of 5‐alpha‐reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia , 2015, Clinical endocrinology.
[59] M. Lewitt,et al. The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus , 2014, Journal of clinical medicine.
[60] P. Pereira. Milk nutritional composition and its role in human health. , 2014, Nutrition.
[61] Robert G. Beiko,et al. A Phylogenomic View of Ecological Specialization in the Lachnospiraceae, a Family of Digestive Tract-Associated Bacteria , 2014, Genome biology and evolution.
[62] G. Ning,et al. IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin. , 2014, Endocrinology.
[63] M. Tomita,et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.
[64] A. LaCroix,et al. Associations of serum insulin-like growth factor-I and insulin-like growth factor-binding protein 3 levels with biomarker-calibrated protein, dairy product and milk intake in the Women's Health Initiative , 2013, British Journal of Nutrition.
[65] J. Foekens,et al. Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma , 2013, Cell.
[66] Z. Kolár̂,et al. Different effect of sodium butyrate on cancer and normal prostate cells. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.
[67] G. Tsujimoto,et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43 , 2013, Nature Communications.
[68] V. Hwa,et al. Current issues on molecular diagnosis of GH signaling defects. , 2013, Endocrine development.
[69] K. Burnstein,et al. Targeting IGF-IR with Ganitumab Inhibits Tumorigenesis and Increases Durability of Response to Androgen-Deprivation Therapy in VCaP Prostate Cancer Xenografts , 2013, Molecular Cancer Therapeutics.
[70] Wei Sun,et al. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. , 2012, Molecular cell.
[71] P. Rotwein. Mapping the growth hormone–Stat5b–IGF-I transcriptional circuit , 2012, Trends in Endocrinology & Metabolism.
[72] I. Kanazawa,et al. Effects of intensive glycemic control on serum levels of insulin-like growth factor-I and dehydroepiandrosterone sulfate in Type 2 diabetes mellitus , 2011, Journal of Endocrinological Investigation.
[73] K. Krohn,et al. TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia. , 2011, Molecular endocrinology.
[74] Takafumi Hara,et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41) , 2011, Proceedings of the National Academy of Sciences.
[75] R. Platt,et al. Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control Study , 2011, PloS one.
[76] T. van Groen,et al. Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. , 2010, The Journal of clinical investigation.
[77] A. Schatzkin,et al. Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. , 2009, Archives of internal medicine.
[78] D. Leroith. Clinical relevance of systemic and local IGF-I: lessons from animal models. , 2008, Pediatric endocrinology reviews : PER.
[79] P. Nelson,et al. An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer , 2007, Clinical Cancer Research.
[80] A. Fukamizu,et al. Insulin-like Growth Factor 1/Insulin Signaling Activates Androgen Signaling through Direct Interactions of Foxo1 with Androgen Receptor* , 2007, Journal of Biological Chemistry.
[81] E. Feldman,et al. Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone. , 2006, Cancer research.
[82] Min Zhang,et al. Total insulin and IGF-I resistance in pancreatic β cells causes overt diabetes , 2006, Nature Genetics.
[83] J. Scharf,et al. Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats. , 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[84] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[85] I. Torres-Aleman,et al. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. , 2004, European journal of pharmacology.
[86] David W. Johnson,et al. The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. , 2004, Kidney international.
[87] Y. Elshimali,et al. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[88] T. Key,et al. Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women , 2003, Cancer Causes & Control.
[89] Y. Kido,et al. Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. , 2002, The Journal of clinical investigation.
[90] S. Hankinson,et al. Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[91] M. Stoffel,et al. β-cell–specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter β-cell mass , 2002, Nature Genetics.
[92] R. Kaaks,et al. Energy balance and cancer: the role of insulin and insulin-like growth factor-I , 2001, The Proceedings of the Nutrition Society.
[93] T. Tammela,et al. Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen. , 2000, The Journal of clinical endocrinology and metabolism.
[94] Dalgleish,et al. Serum insulin‐like growth factor‐1 is not a useful marker of prostate cancer , 1999, BJU international.
[95] Cook Si,et al. Review article: short chain fatty acids in health and disease , 1998 .
[96] P. Marzullo,et al. Prostatic hyperplasia: an unknown feature of acromegaly. , 1998, The Journal of clinical endocrinology and metabolism.
[97] G. Stemmermann,et al. Geographic pathology of latent prostatic carcinoma , 1982, International journal of cancer.
[98] J. Batra,et al. Prostate cancer racial, socioeconomic, geographic disparities: targeting the genomic landscape and splicing events in search for diagnostic, prognostic and therapeutic targets. , 2021, American journal of cancer research.
[99] E. Kelly,et al. an update on , 2014 .
[100] M. Stoffel,et al. beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. , 2002, Nature genetics.
[101] M. Herlyn,et al. Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways. , 2001, Cancer research.